Compare ASMB & OIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASMB | OIS |
|---|---|---|
| Founded | 2005 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 440.0M | 406.3M |
| IPO Year | 2010 | 2000 |
| Metric | ASMB | OIS |
|---|---|---|
| Price | $28.12 | $11.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $43.40 | $14.00 |
| AVG Volume (30 Days) | 94.1K | ★ 1.4M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,088,133,000.00 |
| Revenue This Year | $33.33 | $3.73 |
| Revenue Next Year | N/A | $5.36 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 62.26 |
| 52 Week Low | $7.76 | $3.08 |
| 52 Week High | $39.71 | $14.50 |
| Indicator | ASMB | OIS |
|---|---|---|
| Relative Strength Index (RSI) | 46.78 | 54.02 |
| Support Level | $26.50 | $5.72 |
| Resistance Level | $30.66 | $14.50 |
| Average True Range (ATR) | 1.42 | 0.67 |
| MACD | -0.03 | -0.22 |
| Stochastic Oscillator | 27.35 | 9.97 |
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
Oil States International Inc is a provider of manufactured products and services to the energy, industrial and military sectors. Manufactured products include engineered capital equipment as well as products consumed in the drilling, well construction and production of oil and natural gas. The company sells its products and services to national oil and natural gas companies, oil and natural gas companies, onshore and offshore drilling companies and other oilfield services, defense and industrial companies. The company operates through three business segments, Offshore Manufactured Products, Completion and Production Services and Downhole Technologies. It gains maximum revenue from Offshore Manufactured Products.